A deeper mechanistic understanding is needed, specifically, comprehensive assessment of inflammatory cytokines (IL-1β/6/8, TNF-α), ROS scavenging efficacy, and molecular profiling (qPCR/Western blot) will be incorporated to validate the anti-melanoma mechanisms of pYEEIE-RELNs-DOX. The gene discussed is IL1B; the disease is melanoma.